Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer

TY - JOUR

T1 - Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer

AU - Mahtani, Reshma

N1 - Savill, K. M. Z., Ivanova, J., Asgarisabet, P., Falkenstein, A., Balanean, A., Niyazov, A., Ryan, J. C., Kish, J., Gajra, A., & Mahtani, R. L. (2023). Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer. The oncologist, 28(5), 414–424. https://doi.org/10.1093/oncolo/oyad021

PY - 2023/5/8

Y1 - 2023/5/8

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4933

M3 - Article

VL - 28

JO - Oncologist

JF - Oncologist

ER -